The University of Chicago Header Logo

Connection

Michael P Blair to Infant, Newborn

Back to Details
This is a "connection" page, showing publications Michael P Blair has written about Infant, Newborn.
Michael P Blair
Connection Strength
1.700
Infant, Newborn
  1. Exudative retinal detachment after laser in retinopathy of prematurity. J AAPOS. 2023 12; 27(6):379-381.
    View in: PubMed
    Score: 0.154
  2. Macular Sequelae Following Exudative Retinal Detachment After Laser Photocoagulation for Retinopathy of Prematurity. Ophthalmic Surg Lasers Imaging Retina. 2020 Dec 01; 51(12):698-705.
    View in: PubMed
    Score: 0.126
  3. A Potential Solution to Plus Disease Variability. Ophthalmol Retina. 2020 10; 4(10):1022-1023.
    View in: PubMed
    Score: 0.125
  4. Neurodevelopmental Outcomes Comparing Bevacizumab to Laser for Type 1 ROP. Ophthalmic Surg Lasers Imaging Retina. 2019 06 01; 50(6):337-343.
    View in: PubMed
    Score: 0.114
  5. Foveal Development After Use of Bevacizumab for Aggressive Posterior Retinopathy of Prematurity. Ophthalmic Surg Lasers Imaging Retina. 2019 06 01; 50(6):e185-e187.
    View in: PubMed
    Score: 0.114
  6. Reply. Retina. 2019 01; 39(1):e2-e4.
    View in: PubMed
    Score: 0.111
  7. Bilateral Vitreous Hemorrhage Following Bilateral Intravitreal Injections of Bevacizumab in an Infant With Retinopathy of Prematurity. Ophthalmic Surg Lasers Imaging Retina. 2018 11 01; 49(11):893-896.
    View in: PubMed
    Score: 0.109
  8. Re: Lepore et al.: Follow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings (Ophthalmology. 2018;125:218-226). Ophthalmology. 2018 10; 125(10):e70-e71.
    View in: PubMed
    Score: 0.109
  9. Re: Good: Bevacizumab for retinopathy of prematurity: treatment when pathology is embedded in a normally developing vascular system (Ophthalmology. 2016;123:1843-1844). Ophthalmology. 2017 10; 124(10):e74-e75.
    View in: PubMed
    Score: 0.101
  10. Reactivation of Retinopathy of Prematurity Three Years After Treatment With Bevacizumab. Ophthalmic Surg Lasers Imaging Retina. 2017 03 01; 48(3):255-259.
    View in: PubMed
    Score: 0.097
  11. Very Late Reactivation of Retinopathy of Prematurity After Monotherapy With Intravitreal Bevacizumab. Ophthalmic Surg Lasers Imaging Retina. 2016 Mar; 47(3):280-3.
    View in: PubMed
    Score: 0.091
  12. Fluorescein angiography of recurrent retinopathy of prematurity after initial intravitreous bevacizumab treatment. Arch Ophthalmol. 2010 Aug; 128(8):1080-1.
    View in: PubMed
    Score: 0.062
  13. Association of Health Insurance Status With Severity and Treatment Among Infants With Retinopathy of Prematurity. J Pediatr Ophthalmol Strabismus. 2023 Nov-Dec; 60(6):e75-e78.
    View in: PubMed
    Score: 0.039
  14. Smartphone application links severity of retinopathy of prematurity to early motor behavior in a cohort of high-risk preterm infants. J AAPOS. 2023 02; 27(1):12.e1-12.e7.
    View in: PubMed
    Score: 0.037
  15. Late Vitreoretinal Complications of Regressed Retinopathy of Prematurity: Retinal Break, Vitreous Hemorrhage, and Retinal Detachment. Ophthalmol Retina. 2023 01; 7(1):72-80.
    View in: PubMed
    Score: 0.035
  16. Neurodevelopmental outcomes following bevacizumab treatment for retinopathy of prematurity: a systematic review and meta-analysis. J Perinatol. 2021 09; 41(9):2377-2378.
    View in: PubMed
    Score: 0.033
  17. Two-Year Outcomes Comparing Anti-VEGF Injections to Laser for ROP Using a Commercial Claims Database. Ophthalmic Surg Lasers Imaging Retina. 2020 09 01; 51(9):486-493.
    View in: PubMed
    Score: 0.031
  18. FEVR phenotype associated with septo-optic dysplasia. Ophthalmic Genet. 2019 10; 40(5):449-452.
    View in: PubMed
    Score: 0.029
  19. CANDIDA ENDOPHTHALMITIS FROM THE REACTIVATION OF A DORMANT LENTICULAR FUNGAL ABSCESS IN A PREMATURE INFANT. Retin Cases Brief Rep. 2017 Summer; 11(3):269-271.
    View in: PubMed
    Score: 0.025
  20. CONCURRENT SCLERAL BUCKLE AND INTRAVITREAL BEVACIZUMAB FOR ADVANCED RETINOPATHY OF PREMATURITY-RELATED RETINAL DETACHMENT. Retin Cases Brief Rep. 2016; 10(2):183-6.
    View in: PubMed
    Score: 0.022
  21. Exudative retinopathy and detachment: a late reactivation of retinopathy of prematurity after intravitreal bevacizumab. J AAPOS. 2013 Jun; 17(3):323-5.
    View in: PubMed
    Score: 0.019
  22. Peripheral nonperfusion and tractional retinal detachment associated with congenital optic nerve anomalies. Ophthalmology. 2013 Mar; 120(3):607-615.
    View in: PubMed
    Score: 0.018
  23. Reactivation of retinopathy of prematurity after bevacizumab injection. Arch Ophthalmol. 2012 Aug; 130(8):1000-6.
    View in: PubMed
    Score: 0.018
  24. Significant treatment failure with intravitreous bevacizumab for retinopathy of prematurity. Arch Ophthalmol. 2012 Jun; 130(6):801-2.
    View in: PubMed
    Score: 0.018
  25. Peripheral retinal nonperfusion associated with optic nerve hypoplasia and lissencephaly. Arch Ophthalmol. 2012 Mar; 130(3):398-400.
    View in: PubMed
    Score: 0.017
  26. Acquired vasoproliferative retinal tumor: a late sequela of retinopathy of prematurity. Arch Ophthalmol. 2011 Sep; 129(9):1234-5.
    View in: PubMed
    Score: 0.017
  27. Multiple retinal holes and peripheral nonperfusion in muscle-eye-brain disease. Arch Ophthalmol. 2011 Mar; 129(3):373-5.
    View in: PubMed
    Score: 0.016
  28. Laser photocoagulation at birth prevents blindness in Norrie's disease diagnosed using amniocentesis. Ophthalmology. 2010 Dec; 117(12):2402-6.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.